RCMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RCMT is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong financial performance in the last quarter and analysts have a positive outlook with a raised price target, the technical indicators suggest the stock is overbought. Additionally, there are no significant positive catalysts or trading signals to suggest an immediate entry point. A more patient approach is recommended to wait for a better entry price.
The stock is currently in an overbought condition with an RSI of 88.284. The MACD histogram is positive at 0.858, indicating bullish momentum, but it is contracting. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its resistance level of R1: 29.963, with the next resistance at R2: 32.713. This suggests limited immediate upside potential.
Strong financial performance in Q4 2025, with revenue up 12.43% YoY, net income up 112.91% YoY, and EPS up 118.92% YoY.
Analysts have raised the price target to $36 from $32, citing potential upside in Engineering Services.
The stock is overbought based on RSI, indicating a potential pullback.
No recent news or significant trading trends from hedge funds, insiders, or Congress.
Gross margin has slightly declined YoY.
In Q4 2025, RCMT reported revenue of $86.48M, up 12.43% YoY. Net income increased significantly by 112.91% YoY to $6.10M, and EPS rose 118.92% YoY to 0.81. However, gross margin slightly dropped to 27.43%, down 0.29% YoY.
Benchmark has raised the price target to $36 from $32 and maintains a Buy rating, citing strong Q4 performance and potential upside in Engineering Services. However, they remain cautious about a rebound in Life Sciences in FY26.
